Caricamento...
Pazopanib maintenance therapy after tandem high-dose chemotherapy for disseminated Ewing sarcoma
The dismal prognosis of patients with disseminated Ewing sarcoma necessitates the development of novel treatment strategies. Pazopanib is an oral multi-targeted tyrosine kinase inhibitor that is active against advanced soft tissue sarcoma. However, the clinical activity and feasibility of pazopanib...
Salvato in:
| Pubblicato in: | Int Cancer Conf J |
|---|---|
| Autori principali: | , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Singapore
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6545189/ https://ncbi.nlm.nih.gov/pubmed/31218182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-019-00362-w |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|